Abstract
Glucocorticoids are the mainstay for the treatment of chronic inflammatory diseases including asthma and chronic obstructive pulmonary disease (COPD). However, it has been recognized that glucocorticoids do not work well in certain patient populations suggesting reduced sensitivity. The ultimate biologic responses to glucocorticoids are determined by not only the concentration of glucocorticoids but also the differences between individuals in glucocorticoid sensitivity, which is influenced by multiple factors. Studies are emerging to understand these mechanisms in detail, which would help in increasing glucocorticoid sensitivity in patients with chronic airways disease. This review aims to highlight both classical and emerging concepts of the anti-inflammatory mechanisms of glucocorticoids and also review some novel strategies to overcome steroid insensitivity in airways disease.
Original language | English |
---|---|
Pages (from-to) | 129-143 |
Number of pages | 15 |
Journal | Pulmonary Pharmacology & Therapeutics |
Volume | 29 |
Issue number | 2 |
Early online date | 9 Sept 2014 |
DOIs | |
Publication status | Published - 1 Dec 2014 |
Externally published | Yes |
Keywords
- glucocorticoid
- combination therapy
- steroid resistance
- inflammation
- chronic airway diseases
- asthma